News
TMDX
68.00
+2.83%
1.87
TransMedics Group Signals Growth Amid Margin Squeeze
TipRanks · 21h ago
TransMedics presents at William Blair Growth Stock Conference
PUBT · 1d ago
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference
PR Newswire · 1d ago
Weekly Report: what happened at TMDX last week (0511-0515)?
Weekly Report · 2d ago
Buy Rating Reaffirmed as Analyst Sees Upside Beyond Muted Q1 and Maintains $120 Price Target
TipRanks · 05/13 11:26
TransMedics Buy Rating Reiterated as Analyst Sees Durable DCD-Driven Growth; $124 Price Target Maintained
TipRanks · 05/12 12:35
Weekly Report: what happened at TMDX last week (0504-0508)?
Weekly Report · 05/11 09:56
If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today
Benzinga · 05/08 15:00
TransMedics downgraded to Perform from Outperform at Oppenheimer
TipRanks · 05/07 09:26
TransMedics price target lowered to $85 from $130 at Stifel
TipRanks · 05/07 07:51
TransMedics price target lowered to $124 from $152 at Canaccord
TipRanks · 05/07 06:59
TransMedics price target lowered to $120 from $190 at TD Cowen
TipRanks · 05/07 05:04
AMD upgraded, Reddit downgraded: Wall Street’s top analyst calls
TipRanks · 05/07 04:00
TransMedics price target lowered to $142 from $174 at Needham
TipRanks · 05/07 03:53
TransMedics falls -20.5%
TipRanks · 05/07 03:40
Midday Fly By: Disney, AMD, CVS report quarterly beats
TipRanks · 05/07 03:03
TransMedics Group Leans Into Growth Amid Margin Squeeze
TipRanks · 05/07 00:28
TransMedics: Cheaper, But Still Priced For Perfection
Seeking Alpha · 05/06 23:56
TransMedics Group Is Maintained at Buy by Canaccord Genuity
Dow Jones · 05/06 23:11
TransMedics Group Price Target Cut to $124.00/Share From $152.00 by Canaccord Genuity
Dow Jones · 05/06 23:11
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.